NEW YORK (GenomeWeb) – Georgia Tech spinoff Axion Biosystems announced today that it has closed a $6 million equity financing.

The company, which manufactures the Maestro multiwell microelectrode array platforms, said it will use the proceeds to support the growth of its life science instruments product line. The Georgia Research Alliance Venture Fund led the investment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.